CRISPR and Genome Editing – News and Features

Researchers find that single-parent stem cells can proliferate normally in an adult organ and could provide a less controversial alternative to the therapeutic cloning of embryonic stem cells.

NGI has announced Dr. Tannin Fuja, director of research and chief scientific officer, will testify a public hearing in support of the Iowa Stem Cell Research and Cures Initiative.

Future Medicine’s journal Nanomedicine has been selected for coverage in ISI® services after the publication of only five issues.

DNT to supply EMD Biosciences with Priofect™ transfection reagents based on Priostar™ dendrimers for the DNA and siRNA transfection research markets.

With three human RNAi gene therapy trials now under way, the technique may be among the first to find widespread use for treating human diseases.

Copernicus Therapeutics will utilize the funds for the development its non-viral gene therapy for cystic fibrosis.

The collaboration will focus on development of a gene therapy capable of regulating mitochondrial fatty acid metabolism and insulin resistance.

CRELUX will provide structural biology services including all steps from construct design to a number of complex structures with small molecule inhibitors provided by Bayer.

Roche Pharma will gain access to all the features of the CNS subset of the DrugTarget Database™.

Caliper combines in vitro and in vivo services of Novascreen Biosciences and Xenogen Biosciences to form Discovery Alliances & Services.